| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8615994 | Clinical Lymphoma Myeloma and Leukemia | 2017 | 6 Pages |
Abstract
This study furthers implementation of clinical genomics in MDS and identifies TP53 and IDH2 as targets for pre- or post-transplant therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Mohamed A. Kharfan-Dabaja, Rami S. Komrokji, Qing Zhang, Ambuj Kumar, Athanasios Tsalatsanis, Janelle Perkins, Taiga Nishihori, Teresa Field, Najla Al Ali, Asmita Mishra, David Sallman, Karma Z. Salem, Ling Zhang, Lynn Moscinski, Hugo F. Fernandez,